CN Stock MarketDetailed Quotes
603538 Ningbo Menovo Pharmaceutical
- 13.09
- +0.19+1.47%
Market Closed Dec 27 15:00 CST
2.86BMarket Cap140.75P/E (TTM)
13.14High12.86Low22.07KlotVolume12.94Open12.90Pre Close28.86MTurnover1.04%Turnover Ratio246.98P/E (Static)218.75MShares19.4952wk High1.36P/B2.78BFloat Cap9.9452wk Low14.19Limit Up212.45MShs Float61.72Historical High11.61Limit Down2.17%Amplitude9.11Historical Low0.02Dividend TTM13.07Avg Price11.30KlotAsk0.15%Div YieldTTM100Lot Size10.03KlotBid
Ningbo Menovo Pharmaceutical Key Stats
All
YOY
| (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Current assets | ||||||||||
| Money funds | -21.29%565.45M | -8.15%570.61M | -48.05%351.89M | -42.41%456.04M | 52.13%718.41M | 35.35%621.22M | 57.80%677.39M | 87.76%791.94M | 48.81%472.22M | 62.12%458.99M |
| Transactional financial assets | -0.11%220.46M | 1.08%209.01M | -14.12%265.3M | 23.59%268.65M | -44.26%220.7M | -43.29%206.77M | 7.63%308.9M | -41.47%217.38M | -8.46%395.98M | -20.51%364.64M |
| Notes receivable and accounts receivable | -27.98%211.03M | 59.22%289.16M | 63.09%247.47M | 67.70%283.16M | -2.02%293.01M | -43.53%181.61M | -53.61%151.74M | -19.67%168.84M | 106.10%299.04M | 52.52%321.6M |
| -Notes receivable | ---- | ---- | ---- | --2.74M | ---- | ---- | ---- | ---- | ---- | ---- |
| -Accounts receivable | -27.98%211.03M | 59.22%289.16M | 63.09%247.47M | 66.08%280.42M | -2.02%293.01M | -43.53%181.61M | -53.61%151.74M | -19.67%168.84M | 106.10%299.04M | 52.52%321.6M |
| Other receivables (including interest and dividends) | -19.99%31.76M | 3.03%32.27M | 47.32%48.38M | 38.90%39.51M | 77.55%39.69M | 24.68%31.32M | 129.65%32.84M | 72.12%28.45M | -69.11%22.35M | -67.74%25.12M |
| -Other receivable | ---- | 3.03%32.27M | ---- | ---- | ---- | 24.68%31.32M | ---- | 72.12%28.45M | ---- | -67.74%25.12M |
| Advance payment | 51.25%29.7M | 20.08%19.87M | 11.74%20.23M | -25.44%11.52M | -41.01%19.64M | -77.53%16.54M | -75.60%18.11M | -42.61%15.45M | 24.93%33.29M | 192.55%73.64M |
| Inventories | 12.98%791.94M | 8.39%711.97M | 1.80%659.73M | 3.06%612.6M | 2.18%700.93M | 3.75%656.88M | 12.13%648.07M | 2.54%594.42M | 28.79%685.98M | 31.47%633.14M |
| Receivable financing | 102.15%19.59M | 91.43%19.04M | 136.37%28.32M | 100.45%37.58M | -27.64%9.69M | -59.05%9.95M | -5.35%11.98M | 49.52%18.75M | -32.24%13.39M | 70.46%24.3M |
| Other current assets | 57.76%68.52M | 51.57%57.14M | -11.44%66.61M | -14.94%50.33M | 24.21%43.43M | 66.52%37.7M | 35.89%75.22M | -6.64%59.16M | -43.25%34.96M | -65.41%22.64M |
| Total current assets | -5.23%1.94B | 8.35%1.91B | -12.28%1.69B | -7.13%1.76B | 4.51%2.05B | -8.42%1.76B | 8.23%1.92B | 11.28%1.89B | 21.72%1.96B | 18.98%1.92B |
| Non Current assets | ||||||||||
| Investment real estate | -5.19%16.28M | 1,215.20%16.51M | 1,199.78%16.73M | -69.62%16.95M | -23.88%17.17M | -94.50%1.26M | -94.07%1.29M | 154.93%55.81M | --22.56M | --22.84M |
| Long-term equity investment | 2.05%321.3M | 1.79%318.32M | 5.06%316.98M | 5.07%315.32M | 13.50%314.84M | 6.12%312.73M | -13.38%301.71M | -6.09%300.11M | -11.96%277.39M | 8.15%294.69M |
| Fixed assets | ---- | 3.47%1.26B | ---- | ---- | ---- | 49.19%1.22B | ---- | 49.08%1.26B | ---- | 11.65%818.76M |
| Constru in process | ---- | -5.07%607.27M | ---- | ---- | ---- | -28.90%639.7M | ---- | -31.74%498.9M | ---- | 57.47%899.72M |
| Construction materials | ---- | -14.42%3.66M | ---- | ---- | ---- | -53.10%4.27M | ---- | 37.74%3.98M | ---- | 166.46%9.11M |
| Intangible assets | 15.82%185.24M | 30.05%188.13M | 26.26%177.55M | 16.46%166.23M | -12.76%159.94M | -22.03%144.67M | -26.41%140.62M | -21.54%142.73M | -6.15%183.34M | -6.14%185.54M |
| Development expenditure | -19.50%29.92M | -46.30%22.44M | 13.62%34.98M | 34.45%40.02M | 9.74%37.16M | 57.19%41.79M | 1.61%30.78M | 50.50%29.77M | -44.92%33.86M | -52.31%26.59M |
| Goodwill | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 0.00%22.74M | 0.00%22.74M |
| Long deferred expense | -18.69%13.41M | -14.82%14.14M | -18.88%14.73M | -25.37%15.22M | -24.02%16.49M | -18.37%16.6M | -14.62%18.16M | -4.31%20.39M | 2.12%21.71M | -3.89%20.33M |
| Deferred tax assets | -72.62%37.29M | -69.16%36.75M | -66.73%37.15M | -65.36%42.67M | 315.76%136.18M | 297.00%119.16M | 252.59%111.65M | 270.22%123.18M | -29.85%32.76M | -39.27%30.01M |
| Usufruct assets | -48.90%16.49M | -48.25%16.97M | -49.62%16.87M | -48.38%17.64M | 4.88%32.27M | 5.00%32.79M | 3.96%33.48M | 5.36%34.18M | 647.77%30.77M | 597.69%31.23M |
| Other non current assets | 627.61%180.62M | 306.92%139.33M | 228.48%173.7M | 226.91%167.39M | -74.55%24.82M | -65.99%34.24M | -29.49%52.88M | -19.89%51.2M | 26.10%97.54M | 50.09%100.67M |
| Total non current assets | 2.72%2.68B | 2.29%2.63B | 6.12%2.66B | 5.51%2.66B | 1.78%2.61B | 4.33%2.57B | 4.94%2.5B | 9.83%2.53B | 20.93%2.56B | 23.18%2.46B |
| Total assets | -0.78%4.62B | 4.75%4.54B | -1.88%4.34B | 0.09%4.42B | 2.96%4.65B | -1.27%4.33B | 6.34%4.43B | 10.45%4.42B | 21.27%4.52B | 21.30%4.39B |
| Liabilities | ||||||||||
| Current liabilities | ||||||||||
| Short term loan | 10.87%624.03M | 49.92%621.22M | 2.90%492.03M | 4.61%486.72M | 1.06%562.84M | -23.11%414.37M | 14.48%478.16M | 9.25%465.28M | 22.61%556.95M | 15.81%538.88M |
| Transactional financial liabilities | ---- | -99.72%130.85K | 122.42%16.19M | 186.07%23.56M | 238.98%50.63M | 1,178.19%46.6M | 10,021.28%7.28M | 20,425.95%8.23M | --14.94M | 2,154.31%3.65M |
| Notes payable and accounts payable | 4.94%551.98M | 8.19%527.03M | 1.87%474.14M | 10.89%553.7M | 16.86%525.99M | 9.53%487.15M | 8.63%465.43M | 28.34%499.32M | 36.68%450.11M | 26.19%444.78M |
| -Notes payable | 53.01%224.64M | 17.45%155.87M | 12.27%208.41M | 2.40%196.66M | 32.40%146.82M | 50.83%132.71M | 49.70%185.63M | 82.55%192.06M | -8.25%110.89M | -41.34%87.98M |
| -Accounts payable | -13.67%327.34M | 4.72%371.17M | -5.03%265.73M | 16.20%357.04M | 11.78%379.17M | -0.66%354.44M | -8.10%279.8M | 8.25%307.26M | 62.73%339.22M | 76.22%356.8M |
| Contract liabilities | -11.93%147.86M | 30.59%146.39M | 6.12%172.97M | -21.46%153.09M | 3.41%167.88M | 131.90%112.09M | 254.80%162.99M | 140.46%194.92M | 680.20%162.34M | 247.74%48.34M |
| Salaries payable | 17.68%38.57M | 21.74%33.24M | -1.76%23.48M | 4.90%45.24M | 12.09%32.77M | 0.29%27.3M | 14.06%23.9M | 2.32%43.13M | -13.54%29.24M | 7.18%27.22M |
| Taxs payable | -40.06%21.79M | -9.78%23.47M | -68.89%27.51M | -64.71%25.45M | -19.69%36.36M | -58.25%26.02M | 49.33%88.41M | 108.33%72.12M | 33.99%45.27M | 114.09%62.33M |
| Other payable (including interest and dividends) | 60.35%74.04M | 77.41%72.84M | -1.68%42.13M | -19.93%32.43M | -68.82%46.17M | -79.16%41.06M | 0.51%42.85M | -55.49%40.5M | 620.43%148.09M | 588.45%196.98M |
| -Dividend payable | ---- | --4.27M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| -Other payable | ---- | 67.02%68.57M | ---- | ---- | ---- | -79.16%41.06M | ---- | -55.49%40.5M | ---- | 609.95%196.98M |
| Non current liabilities due within one year | 196.82%132.09M | 70.24%109.16M | -18.34%44.91M | 76.77%56.09M | -43.32%44.5M | -11.52%64.12M | -13.46%55M | -59.92%31.73M | 31.56%78.51M | 19.70%72.47M |
| Other current liabilities | -29.86%1.31M | -32.40%1.31M | -36.41%2.41M | -71.72%1.97M | -32.03%1.87M | -21.08%1.94M | 48.40%3.78M | 80.77%6.97M | 73.00%2.76M | 111.85%2.46M |
| Total current liabilities | 8.35%1.59B | 25.74%1.53B | -2.41%1.3B | 1.18%1.38B | -1.29%1.47B | -12.63%1.22B | 22.83%1.33B | 18.78%1.36B | 56.03%1.49B | 43.05%1.4B |
| Current liabilities | ||||||||||
| Long term loan | -39.71%187.5M | -17.28%228.72M | 16.94%286.5M | 16.15%302M | -9.51%311M | -24.99%276.5M | -36.67%245M | -14.19%260M | 43.15%343.7M | 130.24%368.61M |
| Bonds payable | 5.71%455.99M | 6.04%452.86M | 5.74%443.76M | 6.43%441.96M | 6.15%431.36M | 7.04%427.07M | 5.68%419.68M | -2.13%415.25M | 4.99%406.36M | 4.73%398.97M |
| Long term salaries pay | 0.00%4.85M | 0.00%4.85M | 0.00%4.85M | 0.00%4.85M | 0.00%4.85M | 0.00%4.85M | 0.00%4.85M | 0.00%4.85M | 0.00%4.85M | 0.00%4.85M |
| Deferred tax liabilities | -83.38%16.15M | -86.72%12.88M | -86.94%13.11M | -86.82%13.59M | 34.72%97.19M | 62.72%96.97M | 61.15%100.37M | 53.19%103.12M | 121.80%72.14M | 75.23%59.59M |
| Long term deferred income | -4.41%79.62M | -5.60%80.32M | 13.30%80.16M | 15.46%81.48M | -0.03%83.3M | 14.56%85.09M | 48.23%70.75M | 44.99%70.57M | 89.26%83.32M | 108.28%74.27M |
| Lease liabilities | -57.61%14.92M | -54.88%14.94M | -40.38%18.15M | -48.29%15.69M | 43.56%35.19M | 22.85%33.11M | 0.71%30.45M | 8.25%30.34M | 223.12%24.51M | 751.83%26.95M |
| Total non current liabilities | -21.17%759.03M | -13.97%794.57M | -2.82%846.54M | -2.78%859.57M | 3.00%962.88M | -1.04%923.59M | -6.24%871.1M | 0.91%884.13M | 30.55%934.87M | 50.83%933.26M |
| Total liabilities | -3.34%2.35B | 8.63%2.33B | -2.57%2.14B | -0.38%2.24B | 0.36%2.43B | -7.99%2.14B | 9.39%2.2B | 11.04%2.25B | 45.10%2.42B | 46.07%2.33B |
| Shareholders equity | ||||||||||
| Paid-in capital | 2.51%218.75M | 2.51%218.75M | -0.02%213.35M | 0.01%213.41M | 0.20%213.4M | 0.20%213.4M | 39.99%213.4M | 41.01%213.38M | 42.38%212.99M | 42.38%212.98M |
| Other equity instruments | -0.03%67.58M | -0.02%67.59M | -0.04%67.59M | -0.04%67.59M | -0.04%67.6M | -0.05%67.6M | -0.16%67.61M | -8.27%67.62M | -52.38%67.62M | -52.38%67.63M |
| Capital reserve funds | 8.07%625.62M | 7.58%615.81M | 2.37%582.35M | 3.84%583.45M | 6.25%578.9M | 6.09%572.44M | -10.60%568.89M | -4.32%561.87M | -3.24%544.83M | -4.03%539.6M |
| Surplus reserve funds | 0.00%36.29M | 0.00%36.29M | 0.00%36.29M | 0.00%36.29M | 46.47%36.29M | 46.47%36.29M | 46.47%36.29M | 46.47%36.29M | 0.00%24.78M | 0.00%24.78M |
| Retained profit | 1.26%1.27B | -0.38%1.23B | -4.16%1.22B | -1.91%1.21B | 11.82%1.25B | 12.66%1.23B | 21.39%1.28B | 31.67%1.23B | 18.29%1.12B | 17.56%1.09B |
| Less:Treasury stock | 90.02%58.66M | 90.02%58.66M | -25.24%23.08M | -27.85%23.08M | 12.14%30.87M | 12.14%30.87M | 10.37%30.87M | 14.37%31.99M | 27,392.74%27.53M | 112.56%27.53M |
| Other composite income | 23.92%-926.46K | 12.96%-1.13M | -29.42%-1.08M | -12.96%-1.1M | -721.56%-1.22M | -617.32%-1.3M | -561.36%-833.31K | -1,043.80%-971.19K | 43.91%-148.23K | 199.98%251.49K |
| Specific reserves | 58.83%12.98M | 72.91%11.95M | 104.19%10.68M | 103.45%9.09M | 27.55%8.17M | 17.90%6.91M | -6.23%5.23M | -13.52%4.47M | 23.82%6.41M | 14.38%5.86M |
| Shareholders equity without minority interests | 2.12%2.17B | 1.02%2.12B | -1.25%2.11B | 0.54%2.1B | 9.02%2.13B | 9.35%2.09B | 11.81%2.14B | 19.04%2.08B | 6.44%1.95B | 6.45%1.92B |
| Minority interests | -0.26%93.77M | -0.78%91.34M | 0.14%91.21M | 1.34%89.43M | -35.11%94.01M | -34.52%92.07M | -62.29%91.08M | -61.13%88.25M | -35.25%144.87M | -36.45%140.6M |
| Total shareholder equity | 2.02%2.26B | 0.95%2.21B | -1.19%2.2B | 0.58%2.19B | 5.97%2.22B | 6.35%2.19B | 3.50%2.23B | 9.84%2.17B | 1.90%2.09B | 1.75%2.06B |
| Total liabilityies and equity | -0.78%4.62B | 4.75%4.54B | -1.88%4.34B | 0.09%4.42B | 2.96%4.65B | -1.27%4.33B | 6.34%4.43B | 10.45%4.42B | 21.27%4.52B | 21.30%4.39B |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Lixin Certified Public Accountants (Special General Partnership) | -- | -- | -- | Lixin Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Heat List
CN
Overall
Symbol
Price
% Chg
No Data
